US FDA approves updated Novartis Beovu® label, to include additional safety information
June 11, 2020 01:15 ET | Source: Novartis International AG Novartis worked with US Food and Drug Administration (FDA) to update Beovu (brolucizumab) prescribing information to guide healthcare professionals in…